Following accusations by independent bloggers in Japan and Germany, the American Heart Association (AHA) has issued an Expression of Concern about five papers published in AHA journals co-authored by Hiroaki Matsubara, a prominent cardiologist and researcher at Kyoto Prefectural University in Japan. In addition to his many papers exploring the basic science of the renin-angiotensin system, Matsubara was the…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

New results from studies following more than 120,000 health care professionals link red meat consumption to higher mortality, cardiovascular disease, and cancer. In a paper published in the Archives of Internal Medicine, An Pan and colleagues report findings from up to 22 years of observation among 37,698 men enrolled in the Health Professionals Follow-up Study and…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Michael Ezekowitz is joining the Cardiovascular Research Foundation (CRF) in New York City to start a new center for atrial fibrillation research. Ezekowitz, a cardiologist at the Lankenau Institute for Medical Research in Philadelphia, had been a professor and vice president for clinical research at Lankenau. Recently, Ezekowitz was a co-principal investigator of the RE-LY…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

In recent years, defects in ICD leads have caused recalls and provoked broad concerns among healthcare professionals and patients alike about the safety and reliability of ICDs and other implanted cardiac devices. Now a key player in these events proposes that a computer software program can better monitor ICD leads and provide earlier warnings of…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

In a New York Times Op-Ed piece on Monday, Eric Topol comments on last week’s announcement by the FDA that it was changing the label for statins. Topol focuses on the new warning that statins raise the risk of diabetes. He opens with a provocative statement: We’re overdosing on cholesterol-lowering statins, and the consequence could be a sharp…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

A newly released statement contains detailed recommendations about the requirements necessary for hospitals and physicians to participate in transcatheter aortic valve replacement (TAVR)  programs. The expert consensus document was released jointly by the American College of Cardiology Foundation (ACCF), the Society for Cardiovascular Angiography and Interventions (SCAI), the American Association for Thoracic Surgery (AATS) and the Society for Thoracic…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

The FDA is warning again about interactions between protease inhibitors and certain statins that can lead to rhabdomyolysis. Protease inhibitors are used to treat HIV and hepatitis C. In a safety communication, the agency published a list of statins that should either be avoided or whose dosing levels should be limited when coadministered with protease…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Confirming earlier speculation by a Wall Street analyst, Pfizer and Bristol-Myers Squibb announced on Wednesday evening that the FDA had extended by 3 months the action date for the new drug application (NDA) for the highly anticipated oral anticoagulant apixaban (Eliquis). The application is for their important indication of stroke prevention in atrial fibrillation. The…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.